These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report]. Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308 [No Abstract] [Full Text] [Related]
3. [Outcome of watch and wait strategy or organ preservation for rectal cancer following neoadjuvant chemoradiotherapy: report of 35 cases from a single cancer center]. Wu A; Wang L; Du C; Peng Y; Yao Y; Zhao J; Zhan T; Cai Y; Li Y; Sun Y; Ji J Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):417-424. PubMed ID: 28440523 [TBL] [Abstract][Full Text] [Related]
4. Organ preservation with local excision or active surveillance following chemoradiotherapy for rectal cancer. Creavin B; Ryan E; Martin ST; Hanly A; O'Connell PR; Sheahan K; Winter DC Br J Cancer; 2017 Jan; 116(2):169-174. PubMed ID: 27997526 [TBL] [Abstract][Full Text] [Related]
5. Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial. Garcia-Aguilar J; Renfro LA; Chow OS; Shi Q; Carrero XW; Lynn PB; Thomas CR; Chan E; Cataldo PA; Marcet JE; Medich DS; Johnson CS; Oommen SC; Wolff BG; Pigazzi A; McNevin SM; Pons RK; Bleday R Lancet Oncol; 2015 Nov; 16(15):1537-1546. PubMed ID: 26474521 [TBL] [Abstract][Full Text] [Related]
6. [Long-term prognostic analysis on complete/near-complete clinical remission for mid-low rectal cancer after neoadjuvant chemoradiotherapy]. Wang L; Li S; Zhang X; Sun T; Du C; Chen N; Peng Y; Yao Y; Zhan T; Zhao J; Cai Y; Li Y; Wang W; Li Z; Sun Y; Ji J; Wu A Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Nov; 21(11):1240-1248. PubMed ID: 30506534 [TBL] [Abstract][Full Text] [Related]
7. 'Folfirinox' chemotherapy combined with contact x-ray brachytherapy 50kVp and 'CAP50' chemoradiotherapy aiming at organ preservation for selected intermediate distal-middle cT2-T3 rectal cancers: A feasibility study. Mitrea D; Barbet N; Pacé-Loscos T; Scouarnec C; Ben-Dhia S; Baron D; Mineur L; Évesque L; Durand-Labrunie J; Gérard JP; Baudin G; Doyen J Cancer Radiother; 2024 Aug; 28(4):323-332. PubMed ID: 39003168 [TBL] [Abstract][Full Text] [Related]
8. Planned organ preservation for early T2-3 rectal adenocarcinoma: A French, multicentre study. Gérard JP; Barbet N; Gal J; Dejean C; Evesque L; Doyen J; Coquard R; Gugenheim J; Benizri E; Schiappa R; Baudin G; Benezery K; François E Eur J Cancer; 2019 Feb; 108():1-16. PubMed ID: 30580125 [TBL] [Abstract][Full Text] [Related]
9. Rectal cancer with complete clinical response after neoadjuvant chemoradiotherapy, surgery, or "watch and wait". Lai CL; Lai MJ; Wu CC; Jao SW; Hsiao CW Int J Colorectal Dis; 2016 Feb; 31(2):413-9. PubMed ID: 26607907 [TBL] [Abstract][Full Text] [Related]
10. [Comparison of long-term efficacy between watch and wait strategy and total mesorectal excision in locally advanced rectal cancer patients with clinical complete response after neoadjuvant therapy]. Wang XH; Zhou CJ; Zhang S; Wang QX; Xiao WW; Ding PR; Chen G; Pan ZZ; Zeng ZF; Gao YH Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):266-273. PubMed ID: 32192306 [No Abstract] [Full Text] [Related]
11. Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis. Renehan AG; Malcomson L; Emsley R; Gollins S; Maw A; Myint AS; Rooney PS; Susnerwala S; Blower A; Saunders MP; Wilson MS; Scott N; O'Dwyer ST Lancet Oncol; 2016 Feb; 17(2):174-183. PubMed ID: 26705854 [TBL] [Abstract][Full Text] [Related]
12. [Short-term outcome of programmed cell death protein1 (PD-1) antibody combined with total neoadjuvant chemoradiotherapy in the treatment of locally advanced middle-low rectal cancer with high risk factors]. Li YJ; Zhang L; Dong QS; Cai Y; Zhang YZ; Wang L; Yao YF; Zhang XY; Li ZW; Li YH; Sun YS; Wang WH; Wu AW Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Nov; 24(11):998-1007. PubMed ID: 34823301 [No Abstract] [Full Text] [Related]
13. [Total neoadjuvant therapy followed by watch and wait approach or organ preservation for MRI stratified low-risk rectal cancer: early result from a prospective, single arm trial]. Wang L; Zhao YM; Sun TT; Xu YL; Li SJ; Zhang XY; Cai Y; Li YH; Li ZW; Chen PJ; Peng YF; Wang WH; Wu AW Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):258-265. PubMed ID: 32192305 [No Abstract] [Full Text] [Related]
14. [Evaluation of progression-free survival for locally advanced rectal cancer by MRI after neoadjuvant chemoradiotherapy and total mesorectal excision]. Zhang JX; Yang Z; Fan P; Zhang JJ; Xin L; Hou LN; Du XS; Yang XT Zhonghua Zhong Liu Za Zhi; 2018 Feb; 40(2):121-126. PubMed ID: 29502372 [No Abstract] [Full Text] [Related]
15. A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis. Dossa F; Chesney TR; Acuna SA; Baxter NN Lancet Gastroenterol Hepatol; 2017 Jul; 2(7):501-513. PubMed ID: 28479372 [TBL] [Abstract][Full Text] [Related]
16. Pathologic Complete Response in Rectal Cancer: Can We Detect It? Lessons Learned From a Proposed Randomized Trial of Watch-and-Wait Treatment of Rectal Cancer. Nahas SC; Rizkallah Nahas CS; Sparapan Marques CF; Ribeiro U; Cotti GC; Imperiale AR; Capareli FC; Chih Chen AT; Hoff PM; Cecconello I Dis Colon Rectum; 2016 Apr; 59(4):255-63. PubMed ID: 26953983 [TBL] [Abstract][Full Text] [Related]
17. Rectal Sparing Approach after preoperative Radio- and/or Chemo-therapy (ReSARCh): a prospective, multicenter, observational study. Spolverato G; Bao QR; Delrio P; Guerrieri M; Ortenzi M; Cillara N; Restivo A; Deidda S; Spinelli A; Romano C; Bianco F; Sarzo G; Morpurgo E; Belluco C; Palazzari E; Chiloiro G; Meldolesi E; Coco C; Pafundi DP; Feleppa C; Aschele C; Bonomo M; Muratore A; Mellano A; Chiaulon G; Crimì F; Maretto I; Perin A; Urso EDL; Scarpa M; Bigon M; Scognamiglio F; Bergamo F; Del Bianco P; Gambacorta MA; Rega D; Pucciarelli S Int J Surg; 2024 Aug; 110(8):4736-4745. PubMed ID: 38518084 [TBL] [Abstract][Full Text] [Related]
18. ["Watch and wait" strategy after neoadjuvant therapy for rectal cancer: status survey of perceptions, attitudes and treatment selection in Chinese surgeons]. Sun TT; Wang L; Yao YF; Peng YF; Zhao J; Zhan TC; Leng JH; Wang HY; Chen N; Chen PJ; Li YJ; Zhang X; Liu XZ; Zhang Y; Wu AW Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):550-559. PubMed ID: 31238634 [No Abstract] [Full Text] [Related]
19. Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch & Wait Database: a retrospective, international, multicentre registry study. Fernandez LM; São Julião GP; Figueiredo NL; Beets GL; van der Valk MJM; Bahadoer RR; Hilling DE; Meershoek-Klein Kranenbarg E; Roodvoets AGH; Renehan AG; van de Velde CJH; Habr-Gama A; Perez RO; Lancet Oncol; 2021 Jan; 22(1):43-50. PubMed ID: 33316218 [TBL] [Abstract][Full Text] [Related]
20. Impact of Organ-Preserving Strategies on Anorectal Function in Patients with Distal Rectal Cancer Following Neoadjuvant Chemoradiation. Habr-Gama A; Lynn PB; Jorge JM; São Julião GP; Proscurshim I; Gama-Rodrigues J; Fernandez LM; Perez RO Dis Colon Rectum; 2016 Apr; 59(4):264-9. PubMed ID: 26953984 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]